 Sweta Patel
Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2025 | 122 | 1.590 |
Why?
| | Neoplastic Stem Cells | 5 | 2024 | 399 | 1.540 |
Why?
| | Hematopoietic Stem Cells | 4 | 2024 | 406 | 1.040 |
Why?
| | Transcriptome | 3 | 2022 | 971 | 0.980 |
Why?
| | Myelodysplastic Syndromes | 1 | 2024 | 135 | 0.790 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 94 | 0.670 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.630 |
Why?
| | Metabolome | 1 | 2021 | 350 | 0.560 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2024 | 801 | 0.530 |
Why?
| | Leukemia, Myeloid, Acute | 4 | 2024 | 630 | 0.520 |
Why?
| | Signal Transduction | 2 | 2022 | 5079 | 0.310 |
Why?
| | Bone Marrow Cells | 2 | 2020 | 316 | 0.310 |
Why?
| | Leukemia, Myeloid | 1 | 2025 | 45 | 0.230 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2025 | 224 | 0.220 |
Why?
| | Mice | 9 | 2025 | 17787 | 0.210 |
Why?
| | Glycolysis | 2 | 2024 | 321 | 0.200 |
Why?
| | Cholinergic Agents | 1 | 2022 | 18 | 0.190 |
Why?
| | Cell Lineage | 2 | 2021 | 350 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 449 | 0.180 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2021 | 59 | 0.180 |
Why?
| | GATA2 Transcription Factor | 1 | 2021 | 15 | 0.180 |
Why?
| | Lymphopoiesis | 1 | 2020 | 26 | 0.170 |
Why?
| | Stromal Cells | 1 | 2020 | 112 | 0.170 |
Why?
| | Thymocytes | 1 | 2020 | 36 | 0.170 |
Why?
| | Chemical Fractionation | 1 | 2019 | 26 | 0.160 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 480 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 660 | 0.160 |
Why?
| | Interleukin-1beta | 1 | 2021 | 372 | 0.160 |
Why?
| | Receptors, Prolactin | 1 | 2019 | 7 | 0.160 |
Why?
| | Hematopoiesis | 1 | 2020 | 192 | 0.160 |
Why?
| | Cadherins | 1 | 2021 | 206 | 0.150 |
Why?
| | Receptor, IGF Type 1 | 1 | 2019 | 65 | 0.150 |
Why?
| | Human Growth Hormone | 1 | 2019 | 48 | 0.150 |
Why?
| | Animals | 9 | 2025 | 36940 | 0.150 |
Why?
| | Interleukin-10 | 1 | 2020 | 302 | 0.150 |
Why?
| | Cell Differentiation | 3 | 2021 | 1991 | 0.150 |
Why?
| | Calcium | 1 | 2024 | 1199 | 0.150 |
Why?
| | Mitochondria | 1 | 2024 | 948 | 0.140 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2020 | 385 | 0.140 |
Why?
| | Macrophages | 1 | 2024 | 1547 | 0.130 |
Why?
| | B-Lymphocytes | 1 | 2022 | 847 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 916 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2019 | 771 | 0.110 |
Why?
| | Inflammation | 1 | 2025 | 2837 | 0.110 |
Why?
| | RNA | 1 | 2019 | 921 | 0.100 |
Why?
| | Apoptosis | 1 | 2021 | 2553 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1996 | 0.090 |
Why?
| | Prostatic Neoplasms | 1 | 2019 | 1043 | 0.090 |
Why?
| | Single-Cell Analysis | 2 | 2021 | 313 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2019 | 2253 | 0.060 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2025 | 69 | 0.060 |
Why?
| | Humans | 8 | 2025 | 137585 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4295 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3412 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 193 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 88 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 4193 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 227 | 0.050 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 242 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5757 | 0.050 |
Why?
| | Basophils | 1 | 2021 | 73 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 674 | 0.040 |
Why?
| | Sulfonamides | 1 | 2024 | 513 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2021 | 171 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 239 | 0.040 |
Why?
| | Mast Cells | 1 | 2021 | 147 | 0.040 |
Why?
| | Male | 3 | 2021 | 67762 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.040 |
Why?
| | STAT5 Transcription Factor | 1 | 2019 | 57 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 318 | 0.040 |
Why?
| | Female | 3 | 2021 | 73304 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 315 | 0.040 |
Why?
| | Chronic Disease | 1 | 2025 | 1793 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 908 | 0.040 |
Why?
| | Protein Domains | 1 | 2019 | 289 | 0.030 |
Why?
| | Cytokines | 1 | 2025 | 2085 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1062 | 0.030 |
Why?
| | Cattle | 1 | 2019 | 984 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 539 | 0.030 |
Why?
| | Binding Sites | 1 | 2019 | 1303 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2757 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 644 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 860 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 2129 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1774 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2475 | 0.030 |
Why?
| | DNA | 1 | 2019 | 1459 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3958 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4149 | 0.020 |
Why?
|
|
Patel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|